Although it has been widely known that skeletal muscle is the predominant site of insulin-mediated glucose uptake [17,18] and that abnormalities in the insulin receptor signaling pathway in this tissue are associated with insulin resistance [19,20], there is little information about the metabolic effects of zinc on the insulin-signaling pathway in the skeletal muscle in DM. The gene discussed is INS; the disease is Insulin resistance.